{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:49:00Z","timestamp":1782514140808,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.ajkd.2025.11.019","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:39:54Z","timestamp":1774658394000},"page":"154-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Obesity Management in End-Stage Kidney Disease: Pathways to Improve Kidney Transplant Access"],"prefix":"10.1053","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5600-4452","authenticated-orcid":false,"given":"Pooja","family":"Budhiraja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak J.","family":"Orandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1053\/j.ajkd.2025.11.019_bib1","article-title":"Prevalence of obesity and severe obesity among persons aged 2-19 years\u2014United States, 1999-2000 through 2021-2023","volume":"73","author":"Emmerich","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1053\/j.ajkd.2025.11.019_bib2","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1097\/TP.0000000000004243","article-title":"Trends, social context, and transplant implications of obesity among incident dialysis patients in the United States","volume":"106","author":"Lavenburg","year":"2022","journal-title":"Transplantation"},{"issue":"2S1","key":"10.1053\/j.ajkd.2025.11.019_bib3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajt.2024.01.012","article-title":"OPTN\/SRTR 2022 annual data report: kidney","volume":"24","author":"Lentine","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2025.11.019_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12916-015-0340-5","article-title":"Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis","volume":"13","author":"Lafranca","year":"2015","journal-title":"BMC Med"},{"issue":"10","key":"10.1053\/j.ajkd.2025.11.019_bib5","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.ajt.2025.05.033","article-title":"Practices in the management of kidney transplant candidates and recipients with obesity: a survey of U.S. transplant programs","volume":"25","author":"Puttarajappa","year":"2025","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2025.11.019_bib6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/oby.23195","article-title":"Obesity as an isolated contraindication to kidney transplantation in the end-stage renal disease population: a cohort study","volume":"29","author":"Orandi","year":"2021","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"10.1053\/j.ajkd.2025.11.019_bib7","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ajt.12331","article-title":"The survival benefit of kidney transplantation in obese patients","volume":"13","author":"Gill","year":"2013","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2025.11.019_bib8","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1681\/ASN.0000000512","article-title":"ASN kidney health guidance on the management of obesity in persons living with kidney diseases","volume":"35","author":"Ikizler","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"9403","key":"10.1053\/j.ajkd.2025.11.019_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"issue":"11 suppl 1","key":"10.1053\/j.ajkd.2025.11.019_bib10","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1210\/jc.2008-1595","article-title":"Obesity and the metabolic syndrome in developing countries","volume":"93","author":"Misra","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1053\/j.ajkd.2025.11.019_bib11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/M16-1895","article-title":"Cardiometabolic abnormalities among normal-weight persons from five racial\/ethnic groups in the United States: a cross-sectional analysis of two cohort studies","volume":"166","author":"Gujral","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9491","key":"10.1053\/j.ajkd.2025.11.019_bib12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"issue":"16","key":"10.1053\/j.ajkd.2025.11.019_bib13","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/CIRCULATIONAHA.106.635011","article-title":"Defining obesity cut points in a multiethnic population","volume":"115","author":"Razak","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.ajkd.2025.11.019_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/tri.12782","article-title":"Risk of post-transplantation diabetes mellitus is greater in South Asian versus Caucasian kidney allograft recipients","volume":"29","author":"Peracha","year":"2016","journal-title":"Transpl Int"},{"issue":"16","key":"10.1053\/j.ajkd.2025.11.019_bib15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1053\/j.ajkd.2025.11.019_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.019_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Look","year":"2013","journal-title":"N Engl J Med"},{"issue":"10107","key":"10.1053\/j.ajkd.2025.11.019_bib18","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0140-6736(17)32252-3","article-title":"Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study","volume":"390","author":"Dehghan","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.019_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2215\/CJN.0000000604","article-title":"Weight loss intentionality and frailty are associated with pre-kidney transplant outcomes","volume":"20","author":"Ghildayal","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.019_bib20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3390\/nu15051256","article-title":"Mediterranean dietary pattern adjusted for CKD patients: the MedRen Diet","volume":"15","author":"D\u2019Alessandro","year":"2023","journal-title":"Nutrients"},{"issue":"9","key":"10.1053\/j.ajkd.2025.11.019_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-020-0297-2","article-title":"Plant-based diets to manage the risks and complications of chronic kidney disease","volume":"16","author":"Carrero","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2025.11.019_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.019_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.019_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13841","article-title":"Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity","volume":"26","author":"Mechanick","year":"2025","journal-title":"Obes Rev"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.019_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.ajkd.2023.02.005","article-title":"Patient and health care professional perspectives on addressing obesity in ESKD","volume":"82","author":"Harhay","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2025.11.019_bib26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ijo.2015.59","article-title":"Physiological adaptations to weight loss and factors favouring weight regain","volume":"39","author":"Greenway","year":"2015","journal-title":"Int J Obes (Lond)"},{"issue":"8042","key":"10.1053\/j.ajkd.2025.11.019_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-024-08165-7","article-title":"Adipose tissue retains an epigenetic memory of obesity after weight loss","volume":"636","author":"Hinte","year":"2024","journal-title":"Nature"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.019_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajt.2024.08.016","article-title":"Contemporary prevalence and practice patterns of out-of-sequence kidney allocation","volume":"25","author":"Liyanage","year":"2025","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.019_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/TP.0b013e3181a9ec89","article-title":"A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients","volume":"88","author":"Meier-Kriesche","year":"2009","journal-title":"Transplantation"},{"issue":"9","key":"10.1053\/j.ajkd.2025.11.019_bib30","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/j.1600-6143.2010.03213.x","article-title":"Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes","volume":"10","author":"Schold","year":"2010","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.019_bib31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41591-025-03556-3","article-title":"Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial","volume":"31","author":"Tronieri","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.019_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/oby.23299","article-title":"Use of prescription medications associated with weight gain among US adults, 1999-2018: a nationally representative survey","volume":"30","author":"Hales","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"10.1053\/j.ajkd.2025.11.019_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15414","article-title":"Obesogenic medication use in end-stage kidney disease and association with transplant listing","volume":"38","author":"Orandi","year":"2024","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2025.11.019_bib34","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.019_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.HYP.37.2.250","article-title":"Hypothesis: beta-adrenergic receptor blockers and weight gain: a systematic analysis","volume":"37","author":"Sharma","year":"2001","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.ajkd.2025.11.019_bib36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2215\/CJN.0000000750","article-title":"GLP-1 receptor agonist outcomes, safety, and body mass index change in a national cohort of patients on dialysis","volume":"20","author":"Orandi","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"issue":"19","key":"10.1053\/j.ajkd.2025.11.019_bib37","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.019_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S2213-8587(24)00371-1","article-title":"GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study","volume":"13","author":"Orandi","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.019_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"issue":"11","key":"10.1053\/j.ajkd.2025.11.019_bib40","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2024.4369","article-title":"GLP-1 receptor agonist use and risk of suicide death","volume":"184","author":"Ueda","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.019_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.019_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03190603","article-title":"Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis","volume":"29","author":"Kambia","year":"2004","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.019_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000077841","article-title":"A comparative study on the effects of naltrexone and loratadine on uremic pruritus","volume":"208","author":"Legroux-Crespel","year":"2004","journal-title":"Dermatology"},{"issue":"9041","key":"10.1053\/j.ajkd.2025.11.019_bib44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","article-title":"Randomised crossover trial of naltrexone in uraemic pruritus","volume":"348","author":"Peer","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.019_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1681\/ASN.V113514","article-title":"Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study","volume":"11","author":"Pauli-Magnus","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.019_bib46","doi-asserted-by":"crossref","first-page":"c83","DOI":"10.1159\/000078635","article-title":"Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke: a single dose study","volume":"97","author":"Worrall","year":"2004","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.019_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2125.2007.02866.x","article-title":"Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites","volume":"64","author":"Turpeinen","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.11.019_bib48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.eplepsyres.2014.03.011","article-title":"Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment","volume":"108","author":"Manitpisitkul","year":"2014","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1053\/j.ajkd.2025.11.019_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.ajkd.2024.12.009","article-title":"Associations of topiramate and zonisamide use with kidney stones: a retrospective cohort study","volume":"85","author":"Salka","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.019_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2009.09.011","article-title":"Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up","volume":"55","author":"MacLaughlin","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2025.11.019_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.019_bib52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1053\/j.ajkd.2025.11.019_bib53","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2215\/CJN.01480219","article-title":"Trends in bariatric surgery procedures among patients with ESKD in the United States","volume":"14","author":"Sheetz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2025.11.019_bib54","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1111\/ajt.16779","article-title":"Bariatric surgery prior to transplantation and risk of early hospital re-admission, graft failure, or death following kidney transplantation","volume":"21","author":"Ku","year":"2021","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2025.11.019_bib55","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11695-018-3604-2","article-title":"National postoperative bariatric surgery outcomes in patients with chronic kidney disease and end-stage kidney disease","volume":"29","author":"Cohen","year":"2019","journal-title":"Obes Surg"},{"issue":"12","key":"10.1053\/j.ajkd.2025.11.019_bib56","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/wjs.70162","article-title":"Outcomes after bariatric surgery in older adults with obesity and end-stage kidney disease","volume":"49","author":"Ishaque","year":"2025","journal-title":"World J Surg"},{"issue":"6","key":"10.1053\/j.ajkd.2025.11.019_bib57","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.soard.2019.04.002","article-title":"Bariatric surgery before and after kidney transplantation: long-term weight loss and allograft outcomes","volume":"15","author":"Cohen","year":"2019","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.019_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/ajt.14463","article-title":"Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients","volume":"18","author":"Kim","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2025.11.019_bib59","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/ajt.15650","article-title":"Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy","volume":"20","author":"Kassam","year":"2020","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2025.11.019_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12975","article-title":"Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomy","volume":"31","author":"Diwan","year":"2017","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2025.11.019_bib61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.2014.352","article-title":"Kidney stones are common after bariatric surgery","volume":"87","author":"Lieske","year":"2015","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ajkd.2025.11.019_bib62","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s11695-007-9287-8","article-title":"Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique","volume":"17","author":"Sanchez-Pernaute","year":"2007","journal-title":"Obes Surg"},{"issue":"12","key":"10.1053\/j.ajkd.2025.11.019_bib63","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ajt.2024.07.024","article-title":"Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity","volume":"24","author":"Puttarajappa","year":"2024","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2025.11.019_bib64","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/TP.0000000000000983","article-title":"The impact of obesity on allograft failure after kidney transplantation: a competing risks analysis","volume":"100","author":"Naik","year":"2016","journal-title":"Transplantation"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626008255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626008255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:29:06Z","timestamp":1782512946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626008255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0272638626008255"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.11.019","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity Management in End-Stage Kidney Disease: Pathways to Improve Kidney Transplant Access","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}